China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.38 Mn | 41.08 Mn | 83,566.00 | -154.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.99% |
| Dec 31, 2025 | -49.62% |
| Sep 30, 2025 | 55.46% |
| Jun 30, 2025 | -120.00% |
| Mar 31, 2025 | -86.42% |
| Dec 31, 2024 | 262.04% |
| Sep 30, 2024 | -1,142.97% |
| Jun 30, 2024 | -1,274.72% |
| Mar 31, 2024 | -1,066.39% |
| Dec 31, 2023 | 34.75% |
| Sep 30, 2023 | -2.80% |
| Jun 30, 2023 | -1,004.74% |
| Mar 31, 2023 | -533.56% |
| Dec 31, 2022 | 58.71% |
| Sep 30, 2022 | -1,024.65% |
| Jun 30, 2022 | 417.51% |
| Mar 31, 2022 | -602.41% |
| Dec 31, 2021 | -31.64% |
| Sep 30, 2021 | 28.12% |
| Jun 30, 2021 | 4.20% |